Amanote Research
Register
Sign In
Preclinical Anti-Arthritic Study and Pharmacokinetic Properties of a Potent Histone Deacetylase Inhibitor MPT0G009
Cell Death and Disease
- United Kingdom
doi 10.1038/cddis.2014.133
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Date
April 1, 2014
Authors
I-N Hsieh
J-P Liou
H-Y Lee
M-J Lai
Y-H Li
C-R Yang
Publisher
Springer Science and Business Media LLC
Related search
A Novel Histone Deacetylase Inhibitor, CKD5, Has Potent Anti-Cancer Effects in Glioblastoma
Oncotarget
Oncology
Anti Arthritic Potentials of Piper Betle- A Preclinical Study
Indian Journal of Pharmacy and Pharmacology
Activity of PXD101, a Histone Deacetylase Inhibitor, in Preclinical Ovarian Cancer Studies
Molecular Cancer Therapeutics
Cancer Research
Oncology
Preclinical Validation of AR42, a Novel Histone Deacetylase Inhibitor, as Treatment for Vestibular Schwannomas
Laryngoscope
Otorhinolaryngology
Santacruzamate A, a Potent and Selective Histone Deacetylase Inhibitor From the Panamanian Marine Cyanobacterium cf.Symplocasp.
Journal of Natural Products
Organic Chemistry
Molecular Medicine
Pharmacology
Complementary
Pharmaceutical Science
Analytical Chemistry
Alternative Medicine
Drug Discovery
Selective Inhibition of IL-Gene Expression by 2Trichostatin A, a Potent Inhibitor of Mammalian Histone Deacetylase.
Journal of Antibiotics
Drug Discovery
Pharmacology
Histone Deacetylase Inhibitors as Therapeutic Agents for Cancer Therapy: Drug Metabolism and Pharmacokinetic Properties
Givinostat, a Type II Histone Deacetylase Inhibitor, Induces Potent Caspase-Dependent Apoptosis in Human Lymphoblastic Leukemia
Genes and Cancer
Cancer Research
Genetics
Discovery of N-(2-Aminophenyl)-4-(Bis(2-Chloroethyl)amino)Benzamide as a Potent Histone Deacetylase Inhibitor
Frontiers in Pharmacology
Pharmacology
